Approval · Notice of Compliance 32626 · 2024
MELPHALAN FOR INJECTION: Notice of Compliance 32626
Issued January 30, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32626
- Date
- January 30, 2024
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site of the drug product
- Canadian reference product
- ALKERAN (Aspen Pharmacare Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MELPHALAN FOR INJECTION | Not yet assigned | — |
Medicinal ingredients
- MELPHALAN HCL 50 MG per VIAL